1. Auflage 2022,
Gebunden, Book, Format (B × H): 148 mm x 210 mm
Verlag: Springer, Berlin
Nandy Relationship between R&D and Financial Performance in Indian Pharmaceutical IndustryThe book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Weitere Infos & Material
Chapter 1. Introduction.- Chapter 2. A Profile of the Indian Pharmaceutical Companies.- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies.- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies.- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies.- Chapter 6. Evaluation of Financial Performance in the Global Context.- Chapter 7. Empirical Study.